Building a novel TRUCK by harnessing the endogenous IFN-gamma promoter for cytokine expression
Article in Molecular Therapy (June 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Genetically Engineered CLDN18.2 CAR-T Cells Expressing Synthetic PD1/CD28 Fusion Receptors Produced Using a Lentiviral Vector
Article in Journal of Microbiology (May 2024)
CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies
Article in Frontiers in Immunology (April 2024)